Effects and prices of generic versions of dabrafenib/dabrafenib and trametinib
In overseas markets, there are already pharmaceutical factories producing generic drugs of Dabrafenib and Trametinib, and they are sold in local hospitals or pharmacies. The ingredients, efficacy, and specifications of these generic drugs are basically the same as those of the original drugs, but there may be some differences in manufacturer and price. At present, common generic drug manufacturers of dabrafenib and trametinib include Laos Lucius Pharmaceuticals, Daxiong Pharmaceuticals, Second Pharmaceutical Factory, etc.
Generic drugs are often similar in effectiveness to the brand-name drugs. In clinical trials, many generic versions of dabrafenib and trametinib have shown similar anti-tumor effects to the original drugs. This is particularly important for patients because the timeliness and effectiveness of cancer treatment directly affect the patient's quality of life and survival rate. Studies have shown that there is no significant difference between the generic version of dabrafenib and the original drug in reducing tumor burden, while the generic version of trametinib also has good performance in inhibiting tumor cell proliferation.
Generic drugs usually need to undergo a series of bioequivalence tests before being marketed to ensure that they are as safe as the original drugs. Many studies have shown that generic versions of dabrafenib and trametinib have roughly similar rates of adverse reactions to the originator drugs. When patients use generic drugs, they still need to monitor for common adverse reactions, such as rash, fever, and liver function abnormalities. The management of these side effects is critical to improving patient compliance.
Since the cost of generic drugs is usually much lower than that of the original drug, the current specification is 75mg*120 tablets of the Lao version dabrafenib , and the price per box may be more than 2,000 yuan; the specification is 2mg*30 tablets of the Lao version of trametinib, and the price per box may be more than 1,000 yuan (the price may fluctuate due to exchange rates).
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)